To support Abbot’s DTC initiative, we developed a new landing page about the Confirm Rx Insertable Cardiac Monitor (ICM) that includes information on the symptoms of an irregular heartbeat, Atrial Fibrillation, and how Confirm Rx could help confirm their diagnosis.
On February 15, 2018, DevicePharm will participate with other medical device leaders in the “TMDA Quarterly Meeting”. The meeting focus is: Developing a Winning Strategy. The meeting will be held between 2pm and 4pm at Norris Conference Center, 2525 West Anderson Lane, Suite 365, Austin, TX.
On June 20, 2017, DevicePharm was represented with a featured group of business leaders in the “Women’s Executive Network Leadership Conference” sponsored by AdvaMed. The event, held in Boston, included an amazing group of medical device leaders. The attendance, which set a new event record, included participants ranging from large medical device organizations to emerging tech companies.
Toronto-based 7D Surgical launched the first MvIGS (Machine-vision Image Guided Surgery) platform at the 2017 AANS neurosurgery meeting in Los Angeles. The campaign, “The IGS Promise. Delivered.” resonated with hundreds of surgeons participating in interactive demonstrations throughout the conference.
On June 6, 2017, DevicePharm was honored to make the opening presentation at the 2017 Spring BioBash in Austin, Texas. The presentation was titled, “So You’re Going To Launch”. It was presented to provide a guide for med-tech executives, marketers, and entrepreneurs who are launching new products, companies, and markets.
On May 18, 2017, DevicePharm and Medical Alley Association co-sponsored an event titled “Communicating Value – Marketing Success In A Value-Driven Environment”. The event, held in the iconic Guthrie Theater in downtown Minneapolis, was attended by 200 members of the Minnesota medical device, biotech, diagnostics, and pharmaceutical community.
On May 1, 2017, DevicePharm announced the opening of our new office in Austin, Texas. This office was developed to serve the growing medical technology industry in Austin, Houston, Dallas, and San Antonio.
Clay Wilemon, DevicePharm CEO and Chief Strategy Officer described the motivation for opening the Austin office, “Texas has over 700 medical device, biotech, diagnostics, and pharmaceutical companies.